F/M Emerald Life Sciences Innovation ETF (LFSC)
NASDAQ: LFSC · Real-Time Price · USD
46.82
-0.36 (-0.76%)
At close: Aug 13, 2026, 4:00 PM EDT
46.82
0.00 (0.00%)
After-hours: Aug 13, 2026, 4:15 PM EDT
LFSC Holdings Information
LFSC is an equity ETF with a total of 40 individual holdings. The top holdings are Travere Therapeutics stock at 8.64%, Spyre Therapeutics at 7.68%, Cogent Biosciences at 7.66%, Corcept Therapeutics at 6.34%, and LivaNova at 6.22%.
Total Holdings
40
Top 10 Percentage
55.99%
Asset Class
Equity
ETF Category
Health
Assets
128.07M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | TVTX | Travere Therapeutics, Inc. | 8.64% |
| 2 | SYRE | Spyre Therapeutics, Inc. | 7.68% |
| 3 | COGT | Cogent Biosciences, Inc. | 7.66% |
| 4 | CORT | Corcept Therapeutics Incorporated | 6.34% |
| 5 | LIVN | LivaNova PLC | 6.22% |
| 6 | GH | Guardant Health, Inc. | 5.71% |
| 7 | CYTK | Cytokinetics, Incorporated | 3.97% |
| 8 | UTHR | United Therapeutics Corporation | 3.39% |
| 9 | BLLN | BillionToOne, Inc. | 3.20% |
| 10 | AXSM | Axsome Therapeutics, Inc. | 3.20% |
| 11 | MIRM | Mirum Pharmaceuticals, Inc. | 3.14% |
| 12 | MANE | Veradermics, Incorporated | 3.13% |
| 13 | DNTH | Dianthus Therapeutics, Inc. | 3.11% |
| 14 | SVRA | Savara Inc. | 3.05% |
| 15 | NKTR | Nektar Therapeutics | 3.03% |
| 16 | TRVI | Trevi Therapeutics, Inc. | 2.85% |
| 17 | TMDX | TransMedics Group, Inc. | 2.72% |
| 18 | VRDN | Viridian Therapeutics, Inc. | 2.43% |
| 19 | ICUI | ICU Medical, Inc. | 2.19% |
| 20 | PVLA | Palvella Therapeutics, Inc. | 2.17% |
| 21 | CRVS | Corvus Pharmaceuticals, Inc. | 1.86% |
| 22 | TWST | Twist Bioscience Corporation | 1.58% |
| 23 | CBLL | CeriBell, Inc. | 1.31% |
| 24 | BBIO | BridgeBio Pharma, Inc. | 1.24% |
| 25 | HNGE | Hinge Health, Inc. | 1.14% |
As of Aug 6, 2026